Bioprocess Analyzers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Market is Segmented by Product Type (Substrate Analysis, Metabolite Analysis, and Concentration Detection), Application, and Geography

Market Snapshot

bioprocess-analyzers-market_Market Summary
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 10.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The bioprocess analyzers market is expected to witness a CAGR of 10.1% over the forecast period. The major factors attributing to the growth of the market are, the growing interest of areas like pharmacology and toxicology, and biotechnology in the developing of advanced medicines and vaccines and the increasing demand for production of mammalian proteins are also a major factor propelling the growth of the market. As recombinant proteins not only used in biomedical research but also in treatment, as drugs their demand increases and so the production. As the production of the recombinant proteins increases the market growth increases. However, difficulties faced during the upstream and downstream process due to the small-sized bioprocessing equipment and the relatively high cost of the raw materials are the constraints to the growth of the market.

Scope of the Report

As per the scope of the report, bioprocess is a technique used to produce biological products, such as microbial genetic strain, and commercially useful chemicals through a biological process. The market is segmented by type, application, end user, and geography.

By Product
By Application
Recombinant Proteins
Other Applications
By Type
Substrate Analysis
Metabolite Analysis
Concentration Detection
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Recombinant Protein Segment is Expected to Dominate the Market

  • Recombinant protein is a protein encoded by recombinant DNA that supports expression of the gene and production of protein.
  • Increasing requirement of recombinant proteins (hormones, interferons, interleukins, hematopoietic growth factors, tumor necrosis factors) for medicinal applications is the major factor contributing to the growth of the market. For example Interluekin-2 is an immunotherapy to treat advanced and metastatic melanoma.
  • Growing studies of protien-protein interactions to perform several laboratory techniques, such as ELISA, Western Blot, and immunohistochemistry (IHC) surges the recombinant protein segment in the global bioprocess analyzers market over the forecast period.
Skin Cancer Rates

North America Dominates the Market and is Expected to do the Same during the Forecast Period

North America is expected to dominate the overall bioprocess analyzers market, throughout the forecast period. This is due to factors such as the growing research and development in pharmaceutical and biotechnology companies and the adoption of advanced bioprocess products drive the growth of the North America bioprocess analyzers market. The other factor driving market growth is the presence of major key players in the region. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.

Basal Cell Carcinoma

Competitive Landscape

The bioprocess analyzers market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are F. Hoffmann-La Roche AG, Nova Biomedical Corporation, YSI Inc., Randox Laboratories Ltd, Sartorious AG, Polestar Technologies, Thermo Fisher Scientific, Agilent Technologies, and Groton Biosystems, LLC.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Interest in the Development of Advanced Medicines and Vaccines

      2. 4.2.2 Increasing Demand for Biologics

    3. 4.3 Market Restraints

      1. 4.3.1 Complexity of Upstream and Downstream Processing and Strict Regulations

      2. 4.3.2 High Cost of Raw Materials

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Instruments

      2. 5.1.2 Consumables

    2. 5.2 By Application

      1. 5.2.1 Antibiotics

      2. 5.2.2 Recombinant Proteins

      3. 5.2.3 Biosimilars

      4. 5.2.4 Other Applications

    3. 5.3 By Type

      1. 5.3.1 Substrate Analysis

      2. 5.3.2 Metabolite Analysis

      3. 5.3.3 Concentration Detection

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 F. Hoffmann-La Roche AG

      2. 6.1.2 Nova Biomedical Corporation

      3. 6.1.3 Sartorious AG

      4. 6.1.4 YSI Inc.

      5. 6.1.5 Randox Laboratories Ltd

      6. 6.1.6 Polestar Technologies

      7. 6.1.7 Agilent Technologies

      8. 6.1.8 Groton Biosystems

      9. 6.1.9 Thermo Fisher Scientific

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Bioprocess Analyzers Market market is studied from 2018 - 2026.

The Bioprocess Analyzers Market is growing at a CAGR of 10.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

F. Hoffmann-La Roche AG, Nova Biomedical Corporation, Sartorious AG, YSI, Inc., Polestar Technologies are the major companies operating in Bioprocess Analyzers Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!